Rxivist logo

Cross-sectional IgM and IgG profiles in SARS-CoV-2 infection

By Tugba Ozturk, Christina Howell, Karima Benameur, Richard P Ramonell, Kevin Cashman, Shama Pirmohammed, Leda Bassit, John Roback, Vince C Marconi, Raymond F. Schinazi, Whitney Wharton, F. Eun-Hyung Lee, William Hu

Posted 14 May 2020
medRxiv DOI: 10.1101/2020.05.10.20097535

Background: Accurate serological assays can improve the early diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but few studies have compared performance characteristics between assays in symptomatic and recovered patients. Methods: We recruited 32 patients who had 2019 coronavirus disease (COVID-19; 18 hospitalized and actively symptomatic, 14 recovered mild cases), and measured levels of IgM (against the full-length S1 or the highly homologous SARS-CoV E protein) and IgG (against S1 receptor binding domain [RBD]). We performed the same analysis in 103 pre-2020 healthy adult control (HC) participants and 13 participants who had negative molecular testing for SARS-CoV-2. Results: Anti-S1-RBD IgG levels were very elevated within days of symptom onset for hospitalized patients (median 2.04 optical density [OD], vs. 0.12 in HC). People who recovered from milder COVID-19 only reached similar IgG levels 28 days after symptom onset. IgM levels were elevated early in both groups (median 1.91 and 2.12 vs. 1.14 OD in HC for anti-S1 IgM, 2.23 and 2.26 vs 1.52 in HC for anti-E IgM), with downward trends in hospitalized cases having longer disease duration. The combination of the two IgM levels showed similar sensitivity for COVID-19 as IgG but greater specificity, and identified 4/10 people (vs. 3/10 by IgG) with prior symptoms and negative molecular testing to have had COVID-19. Conclusions: Disease severity and timing both influence levels of IgM and IgG against SARS-CoV-2, with IgG better for early detection of severe cases but IgM more suited for early detection of milder cases.

Download data

  • Downloaded 1,679 times
  • Download rankings, all-time:
    • Site-wide: 11,358
    • In infectious diseases: 1,457
  • Year to date:
    • Site-wide: 19,745
  • Since beginning of last month:
    • Site-wide: 45,401

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide